Form 4: Bausch Health Executive Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Bausch Health's EVP, General Counsel, Seana Carson, sold 440 shares of common stock at $8.35 per share, following a tax withholding transaction of 1,692 shares at $8.37 per share.
Summary
- Seana Carson, EVP and General Counsel at Bausch Health Companies Inc., reported changes in beneficial ownership of the company's stock.
- On November 29, 2024, 1,692 common shares were withheld to cover tax obligations related to vesting Restricted Share Units at a price of $8.37 per share.
- On December 2, 2024, Ms. Carson sold 440 common shares on the open market at a price of $8.35 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 6, 2023.
- Following these transactions, Ms. Carson beneficially owns 433,066 common shares.
Sentiment
Score: 5
Explanation: The document reflects routine insider trading activity under a pre-arranged plan, which is neither positive nor negative for the company's outlook.
Industry Context
This is a routine filing related to insider trading activity, which is common for executives of publicly traded companies. The use of a 10b5-1 plan is a common practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of Rule 10b5-1 trading plans is a standard practice among executives at publicly traded companies, such as those at AbbVie, Amgen, and Gilead Sciences, to manage their stock transactions and avoid potential insider trading issues.
- The volume of shares sold is relatively small compared to the total shares owned by the executive, which is typical for these types of transactions.
- The price at which the shares were sold is consistent with the market price at the time of the transaction, which is also a standard practice.
Stakeholder Impact
- The transactions are unlikely to have a significant impact on shareholders, as they are routine and involve a small portion of the executive's holdings.
Key Dates
| Date | Description |
|---|---|
| 2023-11-06 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 2024-11-29 | Date of tax withholding transaction of 1,692 shares. |
| 2024-12-02 | Date of open market sale of 440 shares. |
| 2024-12-03 | Date of signature on the Form 4 filing. |
Keywords
Bausch Health, insider trading, Form 4, stock sale, Rule 10b5-1, executive, share ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.